Consent
The patient’s written informed consent for publishing of this case report, as well as images, was acquired.
1. Ahmed MS, Kabir MS, Bhuiyan MH. COVID-19: Effects on Eye in Bangladesh. Bangladesh Medical Journal. 2020;49(2):14-8.
2. Park SH. Personal protective equipment for healthcare workers during the COVID-19 pandemic. Infection & chemotherapy. 2020;52(2):165.
3. Bansal R, Markan A, Gautam N, Guru RR, Lakshmi P, Katoch D, et al. Retinal involvement in COVID-19: Results from a prospective retina screening program in the acute and convalescent phase. Frontiers in medicine. 2021;8.
4. Casagrande M, Fitzek A, Püschel K, Aleshcheva G, Schultheiss H-P, Berneking L, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocular immunology and inflammation. 2020;28(5):721-5.
5. Li Y-P, Ma Y, Wang N, Jin Z-B. Eyes on coronavirus. Stem Cell Research. 2021;51:102200.
6. Pedersen NC. A review of feline infectious peritonitis virus infection: 1963–2008. Journal of feline medicine and surgery. 2009;11(4):225-58.
7. Marinho PM, Marcos AA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. The Lancet. 2020;395(10237):1610.
8. Rim JH, Lee S-T, Gee HY, Lee BJ, Choi JR, Park HW, et al. Accuracy of next-generation sequencing for molecular diagnosis in patients with infantile nystagmus syndrome. JAMA ophthalmology. 2017;135(12):1376-85.
9. Savastano MC, Gambini G, Cozzupoli GM, Crincoli E, Savastano A, De Vico U, et al. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2021:1-9.
10. Pereira L, Soares L, Nascimento P. Retinal findings in hospitalised patients with severe COVID-19 [published online ahead of print October 16, 2020]. Br J Ophthalmol doi.10.
11. Vavvas DG, Sarraf D, Sadda SR, Eliott D, Ehlers JP, Waheed NK, et al. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Nature Publishing Group; 2020.
12. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA ophthalmology. 2021;139(10):1131-5.
13. Bhavsar KV, Lin S, Rahimy E, Joseph A, Freund KB, Sarraf D, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Survey of ophthalmology. 2016;61(5):538-65.
14. Hwang CK, Sen HN. Concurrent vascular flow defects at the deep capillary plexus and choriocapillaris layers in acute macular neuroretinopathy on multimodal imaging: A case series. American Journal of Ophthalmology Case Reports. 2020;20:100866.
15. Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, et al. Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation. 2021:1-9.
16. Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021;397(10269):99-111.
17. Agarwal M, Majumder PD, Babu K, Konana VK, Goyal M, Touhami S, et al. Drug-induced uveitis: A review. Indian Journal of Ophthalmology. 2020;68(9):1799.
18. Cunningham Jr ET, Moorthy RS. Vaccine-associated posterior uveitis. LWW; 2020.
19. Cunningham Jr ET, Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-associated uveitis. Taylor & Francis; 2019.
20. Wang K, Chen W, Zhou Y-S, Lian J-Q, Zhang Z, Du P, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. 2020.
21. Hamashima K, Gautam P, Lau KA, Khiong CW, Blenkinsop TA, Li H, et al. Potential modes of COVID-19 transmission from human eye revealed by single-cell atlas. BioRxiv. 2020.
22. Wang Y, Detrick B, Hooks JJ. Coronavirus (JHM) replication within the retina: analysis of cell tropism in mouse retinal cell cultures. Virology. 1993;193(1):124-37.
23. Robbins S, Hamel C, Detrick B, Hooks J. Murine coronavirus induces an acute and long-lasting disease of the retina. Laboratory investigation; a journal of technical methods and pathology. 1990;62(4):417-26.
24. Chin MS, Hooper LC, Hooks JJ, Detrick B. Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). Journal of neuroimmunology. 2014;272(1-2):42-50.
25. Detrick B, Lee MT, Chin MS, Hooper LC, Chan C-C, Hooks JJ. Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection. Journal of neuroimmunology. 2008;193(1-2):28-37.
26. Landecho M, Yuste J, Gándara E, Sunsundegui P, Quiroga J, Alcaide A, et al. COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? Journal of internal medicine. 2021;289(1):116-20.
27. Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550.
28. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis. 2020;18(4):844-7.
29. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-8.
30. Monferrer-Adsuara C, Castro-Navarro V, González-Girón N, Remolí-Sargues L, Ortiz-Salvador M, Montero-Hernández J, et al. A case of bilateral unusual retinal hemorrhages in a COVID-19 patient. European Journal of Ophthalmology. 2020:1120672120984381.